As COVID-19 spreads worldwide, the medical community and pharmaceutical companies have shifted their focus from investigating drugs to quick-fix solutions such as the development of therapeutics and vaccines. Few groups from the United States and China are already planning to begin human trials. This article focuses on COVID-19 vaccine trials that are either underway, or will commence in the near future. Despite containment strategies, COVID-19 is now a pandemic. This has triggered the prospect of developing vaccines and therapeutics against the disease.
More than 35 companies and academic institutions are racing to create a vaccine against the virus. In January 2020, China released the sequence of t he genetic material of SARS-CoV-2, a causative agent of COVID-19. This accelerated the process of vaccine development worldwide. Studies from the United States and China have already…
